Is Rexcel Pharmaceuticals Ltd. (Amalgamated) a good quality company?

Data is not available for this company.

What is Rexcel Pharmaceuticals Ltd. (Amalgamated) share price return in the past 10 years?

Data is not available for this company

What is the share price of Rexcel Pharmaceuticals Ltd. (Amalgamated)?

Company share prices are keep on changing according to the market conditions. The current trading price of Rexcel Pharmaceuticals Ltd. (Amalgamated) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Rexcel Pharmaceuticals . (Amalgamated)?

The latest standalone P/E ratio of Rexcel Pharmaceuticals . (Amalgamated) as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Rexcel Pharmaceuticals Ltd. (Amalgamated)?

The latest standalone P/B ratio of Rexcel Pharmaceuticals Ltd. (Amalgamated) as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Rexcel Pharmaceuticals Ltd. (Amalgamated)?

The 52-week high of Rexcel Pharmaceuticals Ltd. (Amalgamated) is Rs. and the 52-week low is Rs. .

Rexcel Pharmaceuticals Ltd. (Amalgamated) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Rexcel Pharmaceuticals Ltd. (Amalgamated)
Brand: Rexcel Pharmaceuticals . (Amalgamated)

Rexcel Pharmaceuticals Ltd. (Amalgamated) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Rexcel Pharmaceuticals Ltd. (Amalgamated)

BSE: 0 NSE:

Key Metrics

Market Cap

₹0 Cr.

P/E Ratio

0.00

Price to Book (P/B)

0.00

Price to Sales (P/S)

0.00

EV/EBITDA

0.00

Return on Capital Employed (ROCE)

10.49%

Current Price

₹0

Return on Equity (ROE)

10.53%

Return on Assets (ROA)

10.38%

Operating Profit Margin

99.6%

Net Profit Margin

102.26%

Gross Profit Margin

103.3%

Book Value per Share

₹0

Sales Growth (YoY)

-42.52%

Sales Growth (3 Years)

NA%

Operating Profit Growth (1 Year)

-42.66%

Operating Profit Growth (3 Years)

N/A%

Net Profit Growth (1 Year)

-41.21%

52-Week Low / High

₹0 / 0

Net Profit Growth (3 Years)

N/A%

Dividend Yield

0.00%

Promoter Holding

Pledged shares (%)
of Promoter's holding (%)

DeciZen - make an informed investing decision on Rexcel Pharmaceut.

Based on:

Data

M-Cap below 100cr DeciZen not available

Rexcel Pharmaceuticals Ltd. (Amalgamated) stock performance

Key Ratios

Is an attractive stock to invest in?

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Dec'09	Dec'10	Dec'11	TTM
ROCE % ⓘ	8.1%	15.8%	10.5%	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	15.5	26.4	15.2	15
Sales YoY Gr.	-	70.5%	-42.5%	-
Adj EPS ⓘ	12	21.1	12.4	0
YoY Gr.	-	76%	-41.2%	-
BVPS (₹) ⓘ	90.6	111.7	124.1	0
Adj Net Profit ⓘ	15	26.4	15.5	0
Cash Flow from Ops. ⓘ	0	0	-0.2	-
Debt/CF from Ops. ⓘ	0	639	-9.2	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	NA	-42.5%
Adj EPS ⓘ	NA	NA	NA	-41.2%
BVPSⓘ	NA	NA	NA	11.1%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Dec'09	Dec'10	Dec'11	TTM
Return on Equity % ⓘ	13.3	20.9	10.5	0
Op. Profit Mgn % ⓘ	99.8	99.9	99.6	NAN
Net Profit Mgn % ⓘ	96.9	99.9	102.3	0
Debt to Equity ⓘ	0.7	0	0	-
Working Cap Days ⓘ	0	3	10	0
Cash Conv. Cycle ⓘ	0	-399	-411	0

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	0	-
TTM Sales (₹ Cr.)	15.2	-
BVPS (₹) ⓘ	0	-
Reserves (₹ Cr.) ⓘ	143	-
P/BV ⓘ	0.00	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	- / -
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	0
Equity (₹ Cr.)	0
Face Value (₹)	10
Industry PE ⓘ	44.2

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Rexcel Pharmaceut. - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Dec'09	Dec'10	Dec'11
Sales	15.49	26.41	15.18
Operating Expenses ⓘ +	0.03	0.04	0.06
Manufacturing Costs	0	0	0
Material Costs	0	0	0
Employee Cost	0	0.02	0.04
Other Costs ⓘ	0.03	0.02	0.02
Operating Profit ⓘ	15.46	26.37	15.12
Operating Profit Margin (%)	99.8%	99.9%	99.6%
Other Income ⓘ +	0.01	0.02	0.56
Exceptional Items ⓘ	0	0	0
Interest ⓘ	0	0	0
Depreciation ⓘ	0	0	0
Profit Before Tax ⓘ	15.46	26.40	15.68
Tax ⓘ	0.46	0	0.16
Profit After Tax	15	26.40	15.52
PAT Margin (%)	96.9%	99.9%	102.3%
Adjusted EPS (₹)	12.0	21.1	12.4
Dividend Payout Ratio (%)	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Dec'09	Dec'10	Dec'11
Equity and Liabilities
Shareholders Fund +	113.24	139.64	155.16
Share Capital ⓘ	12.50	12.50	12.50
Reserves ⓘ	100.74	127.14	142.66
Debt +	78.62	2.42	1.79
Long Term Debt	78.62	2.42	1.79
Short Term Debt	0	0	0
Minority Interest	0	0	0
Trade Payables	0	0.05	0.05
Others Liabilities ⓘ	0.06	-0	0
Total Liabilities ⓘ	191.92	142.11	157
Fixed Assets
Net Fixed Assets ⓘ +	0.01	0.01	0.01
Gross Block	0.20	0.20	0.20
Accumulated Depreciation	0.19	0.19	0.19
CWIP ⓘ	0	0	0
Investments ⓘ	191.42	141.64	117.32
Inventories	0	0	0
Trade Receivables	0	0	0
Cash Equivalents ⓘ	0.24	0.27	39.05
Others Assets ⓘ	0.25	0.20	0.63
Total Assets ⓘ	191.92	142.11	157

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Dec'10	Dec'11
Cash Flow From Operating Activity ⓘ +	0	-0.19
PBT ⓘ	26.40	15.68
Adjustment ⓘ	-26.43	-15.74
Changes in Working Capital ⓘ	-0.01	0
Tax Paid ⓘ	0.05	-0.13
Cash Flow From Investing Activity ⓘ +	76.21	0.84
Capex	0	0
Net Investments	76.20	39.50
Others ⓘ	0.01	-38.66
Cash Flow From Financing Activity ⓘ +	-76.20	-0.63
Net Proceeds from Shares ⓘ	0	0
Net Proceeds from Borrowing ⓘ	-76.20	-0.63
Interest Paid ⓘ	0	0
Dividend Paid ⓘ	0	0
Others ⓘ	0	0
Net Cash Flow ⓘ	0.02	0.01

Finance Ratio

PARTICULARS	Dec'09	Dec'10	Dec'11
Ratios
ROE (%)	13.25	20.88	10.53
ROCE (%)	8.06	15.81	10.49
Asset Turnover Ratio	0.08	0.16	0.1
PAT to CFO Conversion(x)	0	-0.01	0
Working Capital Days
Receivable Days	0	0	0
Inventory Days	0	0	0
Payable Days	0	0	0

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Rexcel Pharmaceuticals Ltd. (Amalgamated) FAQs

The current trading price of Rexcel Pharmaceut. on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Rexcel Pharmaceut. stood at ₹0.00 Cr

The latest P/E ratio of Rexcel Pharmaceut. as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Rexcel Pharmaceut. as of 31-Dec-1969 is 0.00.

The 52-week high of Rexcel Pharmaceut. is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Rexcel Pharmaceut. is ₹15.18 ( Cr.) .

About Rexcel Pharmaceuticals Ltd. (Amalgamated)

No data to display

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Rexcel Pharmaceuticals Ltd. (Amalgamated) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating